Company Name | Immutep |
---|---|
Website | https://www.immutep.com |
Snippet | Immutep is a leading biotechnology company focused on developing effective autoimmune and cancer immunotherapy treatments such as Lag-3. |
Type | Public |
Founded | 2001 |
Website | www.immutep.com |
Industry | Biotechnology |
Products | IMP321, GSK2831781, CVac LAG-3 Immunotherapy |
Traded as | NASDAQ: IMMPASX: IMM |
Key people | Marc Voigt(CEO)Frédéric Triebel(Chief Scientific and Medical Officer) |
Headquarters | Sydney, AustraliaLeipzig, Germany |
Immutep is part of the Germany company list
Immutep is part of the Biotechnology company list
Have a list of company names and need to update information? Use our Company Search tool.
Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.
Want to update this profile? Please contact us here with a link to the public source verifying the edit.
Powrbot Inc. is a passionate company working on problems using data analytics, automation & machine learning. Our goal is to automate the boring stuff.
Contact Us